1.105
price down icon16.29%   -0.215
after-market 시간 외 거래: 1.06 -0.045 -4.07%
loading
전일 마감가:
$1.32
열려 있는:
$1.16
하루 거래량:
683.03K
Relative Volume:
1.28
시가총액:
$26.18M
수익:
$152.40K
순이익/손실:
$-10.52M
주가수익비율:
-0.4432
EPS:
-2.4931
순현금흐름:
$-4.26M
1주 성능:
+56.74%
1개월 성능:
+60.12%
6개월 성능:
+82.61%
1년 성능:
-14.34%
1일 변동 폭
Value
$1.10
$1.39
1주일 범위
Value
$0.7145
$1.40
52주 변동 폭
Value
$0.40
$1.73

Abvc Biopharma Inc Stock (ABVC) Company Profile

Name
명칭
Abvc Biopharma Inc
Name
전화
510-668-0881
Name
주소
44370 OLD WARM SPRINGS BLVD., FREMONT
Name
직원
19
Name
트위터
Name
다음 수익 날짜
2024-12-13
Name
최신 SEC 제출 서류
Name
ABVC's Discussions on Twitter

ABVC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ABVC
Abvc Biopharma Inc
1.105 26.18M 152.40K -10.52M -4.26M -2.4931
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

Abvc Biopharma Inc 주식(ABVC)의 최신 뉴스

pulisher
Mar 31, 2025

ABVC BioPharma Delays Yearly Report Filing - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 31, 2025
pulisher
Mar 31, 2025

ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Down 22.7% in March - Defense World

Mar 31, 2025
pulisher
Mar 19, 2025

ABVC BioPharma Maintains Lucrative Global Licensing Agreements and Promising CDMO Acquisition, Strengthening Growth Potential - Yahoo Finance

Mar 19, 2025
pulisher
Mar 16, 2025

ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Significant Growth in Short Interest - The AM Reporter

Mar 16, 2025
pulisher
Mar 15, 2025

ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Update - Defense World

Mar 15, 2025
pulisher
Mar 07, 2025

ABVC BioPharma announces CFO resignation, CEO steps in as interim By Investing.com - Investing.com Canada

Mar 07, 2025
pulisher
Mar 07, 2025

ABVC BioPharma announces CFO resignation, CEO steps in as interim - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

ABVC Biopharma Inc On March 5, Leeds Chow Resigns As CFO Of Abvc Biopharma - Marketscreener.com

Mar 07, 2025
pulisher
Mar 05, 2025

ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs - Financial Content

Mar 05, 2025
pulisher
Feb 28, 2025

ABVC BioPharma's CEO Discusses New Drug Development and AI Integration - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 26, 2025

ABVC and BioLite Japan Forge Strategic Alliance to Boost Japanese Biotech Global Expansion - citybuzz -

Feb 26, 2025
pulisher
Feb 26, 2025

ABVC and BioLite Japan Implement Strategy to Advance Japan's Biotech Innovation Into Global Markets - Financial Content

Feb 26, 2025
pulisher
Feb 20, 2025

ABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025 - Yahoo Finance

Feb 20, 2025
pulisher
Feb 18, 2025

Attention Deficit Hyperactivity Disorder Treatment Market - openPR.com

Feb 18, 2025
pulisher
Feb 12, 2025

Positive Market Response in Asia Fuels Potential Revenue Growth for ABVC and BioKey, Marching Into Global Dietary Supplements Market of USD 75.35 Billion - Yahoo Finance

Feb 12, 2025
pulisher
Jan 30, 2025

ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Decline in Short Interest - Defense World

Jan 30, 2025
pulisher
Jan 16, 2025

ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance

Jan 16, 2025
pulisher
Jan 16, 2025

ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Down 42.6% in December - Defense World

Jan 16, 2025
pulisher
Jan 15, 2025

ABVC BioPharma s ADHD and MDD Drug Polygala Tenuifolia a Natural Wonder With Potential of Transforming Mental Health Treatment of More Than 30 Billion Market - Yahoo Finance

Jan 15, 2025
pulisher
Jan 14, 2025

AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees - Yahoo Finance

Jan 14, 2025
pulisher
Jan 14, 2025

Head to Head Review: ABVC BioPharma (NASDAQ:ABVC) vs. Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Price Requirement - Yahoo Finance

Jan 13, 2025
pulisher
Jan 07, 2025

ABVC BioPharma and ForSeeCon: An Update on Alliance's Ophthalmology-Related Products - Yahoo Finance

Jan 07, 2025
pulisher
Jan 03, 2025

ABVC BioPharma Expands Global Patent Portfolio for ADHD Treatment - Citybuzz

Jan 03, 2025
pulisher
Jan 02, 2025

ABVC BioPharma Secures an Additional Patent for ADHD Treatment, in Addition to the Granted U.S. and Australian Patents, Moving Forward to the Global Patent Map of $32.14 Billion Potential Market - Yahoo Finance

Jan 02, 2025
pulisher
Dec 28, 2024

Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Rises By 148.2% - Defense World

Dec 28, 2024
pulisher
Dec 19, 2024

ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21 - The Manila Times

Dec 19, 2024
pulisher
Dec 19, 2024

ABVC BioPharma Seeks to Revolutionize Mental Health - GlobeNewswire

Dec 19, 2024
pulisher
Dec 19, 2024

ABVCAbvc Biopharma Inc Latest Stock News & Market Updates - StockTitan

Dec 19, 2024
pulisher
Dec 13, 2024

ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Down 24.2% in November - Defense World

Dec 13, 2024
pulisher
Dec 11, 2024

ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners - The Manila Times

Dec 11, 2024
pulisher
Dec 11, 2024

ABVC BioPharma Secures $200,000 in First Cash Licensing - GlobeNewswire

Dec 11, 2024
pulisher
Dec 11, 2024

ABVC BioPharma Secures Major Oncology Licensing Deal: $200K Initial Payment, Up to $50M in Future Royalties - StockTitan

Dec 11, 2024
pulisher
Nov 28, 2024

Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Rises By 79.2% - Defense World

Nov 28, 2024
pulisher
Nov 16, 2024

ABVC BioPharma Inc. Reports Operational Profit and Income Growth in Q3 2024 - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

ABVC BioPharma Inc. (ABVC) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

ABVC BioPharma Reports First Operational Profit in Q3 2024, Showcasing Significant Financial Improvement - Citybuzz

Nov 14, 2024
pulisher
Nov 14, 2024

ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

ABVC BioPharma Reports First-Ever Operational Profit, 2,352% Revenue Surge in Q3 | ABVC Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Increase in Short Interest - Defense World

Nov 14, 2024
pulisher
Nov 06, 2024

ABVC BioPharma Enters into Agreement to Exercise Warrants at Reduced Price - Defense World

Nov 06, 2024
pulisher
Oct 24, 2024

ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb - MSN

Oct 24, 2024
pulisher
Oct 22, 2024

ABVC BioPharma secures additional licensing fees - Investing.com

Oct 22, 2024
pulisher
Oct 22, 2024

ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners - The Manila Times

Oct 22, 2024
pulisher
Oct 22, 2024

ABVC BioPharma secures additional licensing fees By Investing.com - Investing.com UK

Oct 22, 2024
pulisher
Oct 19, 2024

ABVC BioPharma switches to new independent accounting firm - Investing.com

Oct 19, 2024
pulisher
Oct 19, 2024

ABVC BioPharma switches to new independent accounting firm By Investing.com - Investing.com UK

Oct 19, 2024

Abvc Biopharma Inc (ABVC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
자본화:     |  볼륨(24시간):